Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 13 studies | 37% ± 16% | |
| retinal rod cell | 8 studies | 40% ± 19% | |
| retinal cone cell | 6 studies | 40% ± 21% | |
| epithelial cell | 3 studies | 35% ± 10% | |
| glutamatergic neuron | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 5 studies | 29% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 945.87 | 328 / 328 | 100% | 12.19 | 178 / 178 |
| esophagus | 100% | 426.59 | 1443 / 1445 | 100% | 9.30 | 183 / 183 |
| prostate | 100% | 525.93 | 245 / 245 | 100% | 13.23 | 501 / 502 |
| breast | 100% | 648.76 | 459 / 459 | 100% | 12.87 | 1115 / 1118 |
| uterus | 100% | 490.42 | 170 / 170 | 100% | 14.17 | 457 / 459 |
| brain | 100% | 571.98 | 2640 / 2642 | 99% | 12.29 | 701 / 705 |
| thymus | 100% | 649.34 | 653 / 653 | 99% | 13.30 | 601 / 605 |
| ovary | 99% | 364.86 | 179 / 180 | 100% | 11.77 | 429 / 430 |
| bladder | 100% | 498.29 | 21 / 21 | 99% | 11.02 | 498 / 504 |
| kidney | 99% | 517.34 | 88 / 89 | 99% | 13.79 | 892 / 901 |
| intestine | 99% | 370.80 | 961 / 966 | 98% | 10.25 | 515 / 527 |
| stomach | 99% | 362.64 | 357 / 359 | 96% | 6.99 | 275 / 286 |
| lung | 96% | 414.58 | 552 / 578 | 100% | 11.37 | 1152 / 1155 |
| skin | 99% | 422.78 | 1795 / 1809 | 92% | 6.69 | 434 / 472 |
| adrenal gland | 100% | 387.25 | 257 / 258 | 89% | 4.45 | 205 / 230 |
| liver | 86% | 178.84 | 194 / 226 | 91% | 6.98 | 368 / 406 |
| adipose | 100% | 671.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 229.27 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.27 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.20 | 1 / 1 |
| blood vessel | 100% | 584.26 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| heart | 91% | 183.34 | 787 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 8.18 | 26 / 29 |
| eye | 0% | 0 | 0 / 0 | 86% | 4.33 | 69 / 80 |
| muscle | 77% | 114.27 | 618 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 24% | 103.05 | 221 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1902042 | Biological process | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO_0006915 | Biological process | apoptotic process |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FAIM |
| Protein name | Fas apoptotic inhibitory molecule 1 Fas apoptotic inhibitory molecule |
| Synonyms | FAIM1 |
| Description | FUNCTION: Plays a role as an inducible effector molecule that mediates Fas resistance produced by surface Ig engagement in B cells. . |
| Accessions | Q9NVQ4 C9JDZ2 ENST00000360570.8 [Q9NVQ4-3] ENST00000393035.6 [Q9NVQ4-1] ENST00000479848.1 ENST00000393034.6 [Q9NVQ4-1] ENST00000464668.5 [Q9NVQ4-1] ENST00000338446.8 [Q9NVQ4-2] |
